Registration Dossier

Diss Factsheets

Administrative data

Description of key information

For the test substance negative in vitro studies on skin and eye irritation and skin corrosion are available. For the  analogue negative in vivo studies are available for skin and eye irritation (see rationale for read-across chapter 13).

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records
Reference
Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
12-06-2013 to 17-06-2013
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: study performed according to the guideline and under GLP
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
Principles of method if other than guideline:
exposure period 15 minutes with post-exposure incubation period of 42 hours
GLP compliance:
yes (incl. QA statement)
Test system:
human skin model
Control samples:
yes, concurrent negative control
Details on study design:
The EpiSKIN assay uses reconstructed human epidermis to assess skin irritation. For the viability test enzymatic conversion of MTT to formazan is used.

In a pre-test direct interaction of the test substance with the detection chemical MTT is assessed.
In the main study triplicate tissues were treated with 30 uL of the test substance during 15 minutes. In addition a negative control (DPBS) and a positive control (5% SDS) were included. After treatment tissues were rinsed, incubated in maintenance fluid for 42 hours at 37 °C and treated with MTT during 3 hours (at 37 °C). After MTT loading a total biopsy of each epidermis (epidermis and collagen) was made, that was suspended in acidified iso-propanol for 3 days and kept in the refrigerator at 1-10°C. Thereafter the optical density of the extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control.
Tissue viability > 50% means non-irritant
Tissue viability ≤ 50% means irritant
Irritation / corrosion parameter:
% tissue viability
Value:
81.8
Negative controls validity:
valid
Positive controls validity:
valid
Remarks:
rel viability 10.6%
Other effects:
The test substance did not interfere with the reduction of MTT to blue formazan salt.

 

Mean OD562 ± SD

Relative mean viability ± SD

Negative control:

0.946 ± 0.119

100 ± 12.6%

Test substance:

0.774 ± 0.021

81.8 ± 2.2%

SDS:

0.100 ± 0.014

10.6 ± 1.5%
Interpretation of results:
GHS criteria not met
Conclusions:
The test substance is non-irritant in the EPISKIN reconstructed human epidermal model.
Criteria used for interpretation of results: other: tissue viability > 50%: non-irritant
Executive summary:

In this assay triplicate reconstructed human skin tissues were treated with 30 uL of the test substance during 15 minutes. After treatment tissues were rinsed, kept for 42 hours and treated with MTT. Optical density of extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 81.8%, which is indicative for non-irritant substances.

The test substance is non-irritant in the EPISKIN reconstructed human epidermal model.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Link to relevant study records
Reference
Endpoint:
eye irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
17-07-2013 to 18-07-2013
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: not formally validated study method
Principles of method if other than guideline:
The SkinEthic reconstructed human corneal epithelium assay is used
GLP compliance:
yes (incl. QA statement)
Details on study design:
The SkinEthic reconstructed human corneal epithelium assay uses corneal epithelial tissue to assess penetration and concomittant cytotoxicity of the test substance.

In a pre-test direct interaction of the test substance with the detection chemical MTT is assessed.
In the main study triplicate SkinEthic tissues were treated with 30 uL of the test substance during 10 minutes. In addition a negative control (Na2HPO4 0.142 g/L; glucose 1.802 g/L; HEPES 7,149 g/L; KCl 0.224 g/L; NaCl 7.597 g/L) and a positive control (2% SDS) were included. After treatment tissues (3 per treatment) were rinsed and treated with MTT. Optical density of extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control.
Tissue viability ≥ 60% means non-irritant
Tissue viability < 60% means irritant
Irritation parameter:
other: % tissue viability
Value:
89.4
Negative controls validity:
valid
Positive controls validity:
valid
Remarks:
6.7% rel viability
Other effects:
The test substance did not interfere with the reduction of MTT to blue formazan salt.

 

Mean OD562

Relative mean viability

Negative control:

0.940

100%

Test substance:

0.840

89.4%

SDS:

0.063

6.7%
Interpretation of results:
GHS criteria not met
Conclusions:
The test substance is non-irritant in the SkinEthic reconstructed human corneal epithelium assay.
Criteria used for interpretation of results: other: < 60% viability is indicative for positive result
Executive summary:

In this assay triplicate SkinEthic tissues were treated with 30 uL of the test substance during 10 minutes. After treatment tissues were rinsed and treated with MTT. Optical density of extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 89.4%, which is indicative for non-irritant substances.

As the assay is not formally validated, the results need to be regarded as preliminary.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Skin irritation/corrosion

In the EPISKIN assay triplicate reconstructed human skin tissues were treated with 30 uL of the test substance during 15 minutes. After treatment tissues were rinsed, kept for 42 hours and treated with MTT. Optical density of extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 81.8%, which is indicative for non-irritant substances (Harlan 2013g).

In the EpiSKIN test, duplicate reconstructed human skin tissues were treated with 50 uL of the test substance during 3, 60 and 240 minutes. After treatment tissues were rinsed with PBS and incubated with MTT for 3 hours (at 37°C, 5% CO2 in air). Optical density of homogene solutions of MTT treated tissues was measured at 540 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 96.9 -107.4% for the different exposure times, which is indicative for non-corrosive substances (Harlan 2013h).

Eye irritation

In SkinEthic assay tissues (in triplicate) were treated with 30 uL of the test substance during 10 minutes. After treatment tissues were rinsed and treated with MTT. Optical density of extracted MTT solutions was measured at 562 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 89.4%, which is indicative for non-irritant substances (Harlan 2013i).


Justification for classification or non-classification

The test substance does not need to be classified for skin and eye irritation.